These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 36555579)

  • 21. Interleukin-1β suppression dampens inflammatory leucocyte production and uptake in atherosclerosis.
    Hettwer J; Hinterdobler J; Miritsch B; Deutsch MA; Li X; Mauersberger C; Moggio A; Braster Q; Gram H; Robertson AAB; Cooper MA; Groß O; Krane M; Weber C; Koenig W; Soehnlein O; Adamstein NH; Ridker P; Schunkert H; Libby P; Kessler T; Sager HB
    Cardiovasc Res; 2022 Oct; 118(13):2778-2791. PubMed ID: 34718444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interplay between hypercholesterolaemia and inflammation in atherosclerosis: Translating experimental targets into clinical practice.
    Tuñón J; Bäck M; Badimón L; Bochaton-Piallat ML; Cariou B; Daemen MJ; Egido J; Evans PC; Francis SE; Ketelhuth DF; Lutgens E; Matter CM; Monaco C; Steffens S; Stroes E; Vindis C; Weber C; Hoefer IE;
    Eur J Prev Cardiol; 2018 Jun; 25(9):948-955. PubMed ID: 29759006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atherosclerosis: perspectives of anti-inflammatory therapy.
    Nasonov EL; Popkova TV
    Ter Arkh; 2018 May; 90(5):4-12. PubMed ID: 30701884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease.
    Abbate A; Toldo S; Marchetti C; Kron J; Van Tassell BW; Dinarello CA
    Circ Res; 2020 Apr; 126(9):1260-1280. PubMed ID: 32324502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical value of drugs targeting inflammation for the management of coronary artery disease.
    Duchatelle V; Kritikou EA; Tardif JC
    Can J Cardiol; 2012; 28(6):678-86. PubMed ID: 22926034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammation in Coronary Atherosclerosis and Its Therapeutic Implications.
    Montarello NJ; Nguyen MT; Wong DTL; Nicholls SJ; Psaltis PJ
    Cardiovasc Drugs Ther; 2022 Apr; 36(2):347-362. PubMed ID: 33170943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on the Inflammatory Hypothesis of Coronary Artery Disease.
    Boland J; Long C
    Curr Cardiol Rep; 2021 Jan; 23(2):6. PubMed ID: 33409720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating cytokines reflect the expression of pro-inflammatory cytokines in atherosclerotic plaques.
    Edsfeldt A; Grufman H; Asciutto G; Nitulescu M; Persson A; Nilsson M; Nilsson J; Gonçalves I
    Atherosclerosis; 2015 Aug; 241(2):443-9. PubMed ID: 26074318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colchicine for acute and chronic coronary syndromes.
    Imazio M; Andreis A; Brucato A; Adler Y; De Ferrari GM
    Heart; 2020 Oct; 106(20):1555-1560. PubMed ID: 32611559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-6 Signaling in Atherosclerosis: From Molecular Mechanisms To Clinical Outcomes.
    Papastamos C; Antonopoulos AS; Simantiris S; Koumallos N; Sagris M; Theofilis P; Oikonomou E; Siasos G; Tsioufis K; Tousoulis D
    Curr Top Med Chem; 2023; 23(22):2172-2183. PubMed ID: 37464827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunotherapy for the prevention of atherosclerotic cardiovascular disease: Promise and possibilities.
    Khambhati J; Engels M; Allard-Ratick M; Sandesara PB; Quyyumi AA; Sperling L
    Atherosclerosis; 2018 Sep; 276():1-9. PubMed ID: 30006321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-inflammatory therapies for cardiovascular disease.
    Ridker PM; Lüscher TF
    Eur Heart J; 2014 Jul; 35(27):1782-91. PubMed ID: 24864079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coronary atherosclerotic plaque progression: contributing factors in statin-treated patients.
    Clark D; Puri R; Nissen SE
    Expert Rev Cardiovasc Ther; 2020 Dec; 18(12):873-880. PubMed ID: 33048622
    [No Abstract]   [Full Text] [Related]  

  • 34. Inflammation and cardiovascular diseases: lessons from seminal clinical trials.
    Liberale L; Montecucco F; Schwarz L; Lüscher TF; Camici GG
    Cardiovasc Res; 2021 Jan; 117(2):411-422. PubMed ID: 32666079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-inflammatory strategies for atherosclerotic artery disease.
    Agnello F; Capodanno D
    Expert Opin Drug Saf; 2022 May; 21(5):661-672. PubMed ID: 35094611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [ANMCO Position paper: Colchicine as a therapeutic agent in coronary syndromes].
    Di Fusco SA; Imazio M; Rizzello V; Gatto L; Spinelli A; Aquilani S; Riccio C; Caldarola P; Nardi F; De Luca L; Gulizia MM; Gabrielli D; Oliva F; Colivicchi F
    G Ital Cardiol (Rome); 2023 Aug; 24(8):665-674. PubMed ID: 37492875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of interleukin 1β inhibition in cardiovascular disease.
    Qamar A; Rader DJ
    Curr Opin Lipidol; 2012 Dec; 23(6):548-53. PubMed ID: 23069985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-atherosclerotic effect of the angiotensin 1-7 mimetic AVE0991 is mediated by inhibition of perivascular and plaque inflammation in early atherosclerosis.
    Skiba DS; Nosalski R; Mikolajczyk TP; Siedlinski M; Rios FJ; Montezano AC; Jawien J; Olszanecki R; Korbut R; Czesnikiewicz-Guzik M; Touyz RM; Guzik TJ
    Br J Pharmacol; 2017 Nov; 174(22):4055-4069. PubMed ID: 27935022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammatory Cytokines and Atherosclerotic Plaque Progression. Therapeutic Implications.
    Sterpetti AV
    Curr Atheroscler Rep; 2020 Oct; 22(12):75. PubMed ID: 33025148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Update on Inflammation in Atherosclerosis: How to Effectively Treat Residual Risk.
    Mohammadnia N; Opstal TSJ; El Messaoudi S; Bax WA; Cornel JH
    Clin Ther; 2023 Nov; 45(11):1055-1059. PubMed ID: 37716836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.